Bringing HCPs and Patients Together to Realize CBD Benefits

March 4, 2023

The cannabis plant has more than 80 chemical compounds, of which the two most known are THC (marijuana) and CBD. CBD, or cannabidiol, is a hemp derivative that does not elicit abuse or dependence, and research suggests it could potentially help health conditions such as anxiety, chronic pain, arthritis, and addiction, among others.

How do CBD products get into the hands of people who struggle with these conditions, and how do they compare to pharmaceutical products?

On today’s episode of Highway to Health, host David Kemp spoke with Chad Collins, co-founder and CEO, and Reggie Gatewood, co-founder, both of Corganics, to talk about the basics of the CBD market and what Corganics is doing to facilitate improved patient access to CBD products for health conditions.

Kemp, Collins, and Gatewood also discussed…

  1. The origin story, mission, and vision of Corganics
  2. How Corganics educates healthcare providers to educate patients on the CBD market and products
  3. What Corganics is doing to advocate for patient access to their products

Gatewood explained the two key reasons Corganics exists. “One in five Americans is using some sort of CBD… Three in five see it as valid medical therapy. But the two big issues as to why we do what we do are: healthcare professionals are not involved… We educate them and the patients. And also, the wild inconsistency and the quality. We’ve got to treat it like it’s truly a pharmaceutical grade.”

“For us at Corganics, there’s the future of prescriptions, and then there’s the ‘Wild West’ retail version of CBD. And our quality is off the charts—it is more like pharma. So, we self-regulate versus what you find down the street here,” Collins added.

Chad Collins is the co-founder and CEO of Corganics and the author of Run to Fire. Collins previously served as Vice President of Galderma and President and CEO of the Boston Select Asset Group and has racked up twenty years of experience in the healthcare system, including biopharmaceuticals, payor systems, medical devices, and more. He holds a BBA in Marketing from Texas Tech University, an MBA in General Management from Cornell University, and he attended the Executive Education Program at Harvard Business School.

Reggie Gatewood is co-founder of Corganics and previously worked at Sanofi in a multitude of roles, including US Sales Lead, Specialty Channels, Head, Leadership Development and Business Planing, Sanofi North America, and Vice President, Business Excellence. Gatewood attended Northwestern State University, where he earned a BA in journalism and public relations with a marketing emphasis. Gatewood is certified in Prosci Change Management from The Life Cycle Institute, is an Associate Certified Coach from the International Coaching Federation, and has a Coach Advantage certification from The Pyramid Resource Group, Inc.

Recent Episodes

remake medicine
View episode

  Can art help remake medicine with the therapeutic potential to make a difference in healthcare? The rise of holistic approaches to well-being provides an opportunity to bring out the artistic side in healthcare. And on the latest episode of the Healthcare Rethink Podcast, host Brian Urban takes a deeper look into that intersection between […]

provider experience
View episode

  Improving healthcare is a multifaceted challenge, with the provider experience playing a pivotal role alongside patient care. In a recent episode of the “Highway to Health” podcast, host David Kemp delved into this critical issue with Stephanie Prechowski, MBA, MSN, RN, AGCNS-BC, CNOR, Chief Operating Officer at Surgeons Choice Medical Center. In this episode, […]

View episode

  For a special segment of HealthTrio, the topic turns to the innovative use of SaaS in healthcare, which is currently a trending subject at the forefront of modern medical technology. The episode briefly looked into how SaaS platforms are revolutionizing healthcare management and patient outcomes. This episode featured Geoffrey M. Roche, the Executive Advisor […]